Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT04418089 Completed - Breast Cancer Clinical Trials

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

Start date: January 15, 2018
Phase: Phase 2
Study type: Interventional

Introduction: Neoadjuvant chemotherapy (NACT) has been the standard therapy for treating patients with locally advanced breast cancer (LABC). Doxorubicin-based regimen showed a clinical response for 70-80%. However, the cardiotoxicity from it was not tolerable. Simvastatin acts synergistically with doxorubicin against MCF-7 cells, through downregulation of the cell cycle or induction of apoptosis. Also, it alleviates doxorubicin cardiotoxicity by attenuating ER stress and activating the Akt pathway. Hmgcris a new pathway mediating doxorubicin-induced cell death, and cholesterol control drugs combined with doxorubicin could enhance efficacy and reduce side effects. This study is conducted to see the combination simvastatin and CAF would increase the NACT response and surgical margin of LABC patients. Methods: This study was a double-blind, randomized placebo-controlled trial, conducted in dr. Cipto Mangunkusumo General Hospital and Koja General Hospital. A total of 70 LABC patients were assessed for eligibility. Patients received either a combination of CAF-Simvastatin (40 mg/day) or CAF-Placebo. The biopsy was taken pre-NACT to make the histopathological diagnosis and examine the expression of HMG-CoA Reductase (Hmgcr) and P-glycoprotein (P-gp). Patients were evaluated for the clinical response after 3 cycles. If the response was positive, patients will proceed to surgery. Then, the post-operative specimen will be reviewed for the pathological response. However, if it was a negative response, patients will be given 2nd line NACT.

NCT ID: NCT04414033 Completed - Breast Cancer Clinical Trials

Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast Cancer

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates the potential of a unique artificial intelligence-virtual reality intervention called Bubble, to reduce the number and intensity of hot flashes and their accompanying psychological symptoms in women, aged 28-55, with breast cancer. A sample of 37 women with breast cancer were selected to the study. Participants were asked to answer a survey before and after using Bubble. The treatment period was 24 days. The findings are positive and show that the use of Bubble help to reduce several psychological symptoms connected to hot flashes.

NCT ID: NCT04408560 Completed - Clinical trials for Breast Cancer Female

Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer

ARHOMA2
Start date: September 13, 2018
Phase: N/A
Study type: Interventional

Interventional, randomised, prospective, monocentric study

NCT ID: NCT04406779 Completed - Breast Cancer Clinical Trials

The Frequency of Thyroid Diseases in Women With Breast Cancer

Start date: March 1, 2016
Phase:
Study type: Observational

Breast cancer and thyroid disorders are important health challenges commonly encountered in women. The relationship between both conditions still remains unknown. In this study, the frequency of thyroid diseases was investigated in breast cancer patients

NCT ID: NCT04402606 Completed - Breast Cancer Clinical Trials

Study on Skin Toxicities Induced by Cancer Treatments

DERMACLIC
Start date: November 25, 2020
Phase: N/A
Study type: Interventional

The skin toxicities will be evaluated on patient (male or female) with an indication of cancer treatment in the case of solid tumor of the breast, or lung.

NCT ID: NCT04397744 Completed - Breast Cancer Clinical Trials

Unidas Por Vida y Salud: Increasing Breast and Cervical Cancer Screening in El Paso

Start date: January 16, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to develop, implement and evaluate a comprehensive breast and cervical cancer screening program designed to increase uptake of breast and cervical cancer screening among rarely and never-screened low-income women in El Paso County and to increase repeat screening among those currently overdue.

NCT ID: NCT04397419 Completed - Breast Cancer Clinical Trials

Red Bull Energy Drink Intake After Autologous Microsurgical Breast Reconstruction

Start date: May 11, 2020
Phase: N/A
Study type: Interventional

The success rate of autologous microsurgical breast reconstruction depends on adequate intraoperative and postoperative flap perfusion. Perfusion is optimized intraoperatively by a full hyperdynamic circulation and maintenance of a normal body temperature. Additional safe and simple postoperative measures to guarantee adequate perfusion pressure would be desirable. Recently, the effect of Red Bull® Energy Drink on cardiovascular and renal function, pain tolerance as well as performance has been studied in clinical trials involving healthy volunteers and athletes. Notably, an increase in blood pressure, heart rate, improved endothelial function and reduced pain perception have been observed. A better understanding of its effects in patients undergoing autologous microsurgical breast surgery would be of great value. When ingested in standard amounts, Red Bull® Energy Drink has been shown to be a safe beverage without notable side effects. The investigators prospectively study the effect of postoperative oral ingestion of Red Bull® Energy Drink on perfusion-related variables and patient recovery after autologous microsurgical breast reconstruction.

NCT ID: NCT04394247 Completed - Breast Cancer Clinical Trials

Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy

Start date: June 30, 2020
Phase:
Study type: Observational

The study is designed to describe patient characteristics, treatment patterns, and clinical effectiveness outcomes in patients diagnosed with HR+/HER2- A/MBC who received palbociclib combination therapy with AI as first-line treatment in the US community oncology setting.

NCT ID: NCT04379908 Completed - Breast Cancer Clinical Trials

Healthy Lifestyles and Quality of Life in Women With Breast Cancer

Start date: November 7, 2017
Phase:
Study type: Observational [Patient Registry]

A cross-sectional, multicenter, and observational study designed to update clinical, pathological, and lifestyle information for a cohort of approximately 1245 breast cancer patients included in the epiGEICAM-01 study.

NCT ID: NCT04372862 Completed - Clinical trials for Breast Cancer Postoperative Pain

Comparison Between Serratus Anterior Plane Block and Erector Spinae Plane Block for Mastectomy

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

In this study, we are comparing two different techniques of plane blocks to control postoperative mastectomy pain serratus anterior plane block and erector spinae plane block, both are done with ultrasonic guidance We are recording the first time of analgesia request postoperatively as a primary outcome